Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments?
Seiler, R., Gibb, E., Wang, N.Q., Oo, H.Z., Lam, H.-M., Takhar, M., Erho, N., Van Kessel, K., Winters, B., Douglas, J., Lopez, F.V., Crabb, S., Van Rhijn, B., Fransen Van De Putte, E., Zwarthoff, E.,Volume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)31297-1
Date:
March, 2018
File:
PDF, 85 KB
english, 2018